Simulations Plus, Inc.
SLPHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeSimulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. With a market capitalization of $374.2M, it sits in small-cap territory. It operates through Software and Services segments.
Market Cap
$374.2M
Beta
1.31
P/E (TTM)
46.25
P/E (Fwd)
20.96
EPS (TTM)
$0.40
EPS (Fwd)
$0.88
ROE
6.2%
ROA
5.5%
Cash
$50.0M
Total Debt
$487,000
Free CF
$18.4M
52W Change
12.1%
Annual Financials
Cash vs Debt
Where SLP stands vs its 150-day and 200-day moving averages
As of the October 7, 2026 close, SLP finished 13.71% above its 150-day moving average ($16.27) and 13.15% above its 200-day moving average ($16.35). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SLP overbought or oversold?
At the October 7, 2026 close, SLP's RSI(14) was 65.2, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $50.0M in cash comfortably exceeding the $487K debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow comes in at $18.4M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 6.2% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $53.9M (2022) to $79.2M (2025), reflecting a 47% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Simulations Plus, Inc. and its sector.